scleroderma

X-linked inhibitor of apoptosis protein (XIAP) inhibition in systemic sclerosis (SSc)
Christina Bergmann, Ludwig Hallenberger, Sara Chenguiti Fakhouri, Benita Merlevede, Amelie Brandt, Clara Dees, Honglin Zhu, Ariella Zehender, Xiang Zhou, Annemarie Schwab, Chih-Wei Chen, Andrea Hermina Györfi, Alexandru Emil Matei, Debomita Chakraborty, Thuong Trinh-Minh, Simon Rauber, Roland Coras, Aline Bozec, Alexander Kreuter, Mirjana Ziemer, Georg Schett, Jörg H W Distler

Annals of the Rheumatic Diseases Aug 2021, 80 (8) 1048-1056; DOI: 10.1136/annrheumdis-2020-219822
Autoantibodies targeting telomere-associated proteins in systemic sclerosis
Brittany L Adler, Francesco Boin, Paul J Wolters, Clifton O Bingham, Ami A Shah, Carol Greider, Livia Casciola-Rosen, Antony Rosen

Annals of the Rheumatic Diseases Jul 2021, 80 (7) 912-919; DOI: 10.1136/annrheumdis-2020-218918
Targeting human plasmacytoid dendritic cells through BDCA2 prevents skin inflammation and fibrosis in a novel xenotransplant mouse model of scleroderma
Rebecca L Ross, Clarissa Corinaldesi, Gemma Migneco, Ian M Carr, Agne Antanaviciute, Christopher W Wasson, Antonio Carriero, Jörg H W Distler, Steve Holmes, Yasser M El-Sherbiny, Clive S McKimmie, Francesco Del Galdo

Annals of the Rheumatic Diseases Jul 2021, 80 (7) 920-929; DOI: 10.1136/annrheumdis-2020-218439
Arg206Cys substitution in DNASE1L3 causes a defect in DNASE1L3 protein secretion that confers risk of systemic lupus erythematosus
Latanya N Coke, Hongxiu Wen, Mary Comeau, Mustafa H Ghanem, Andrew Shih, Christine N Metz, Wentian Li, Carl D Langefeld, Peter K Gregersen, Kim R Simpfendorfer

Annals of the Rheumatic Diseases Jun 2021, 80 (6) 782-787; DOI: 10.1136/annrheumdis-2020-218810
PASTUL questionnaire: a tool for self-assessment of scleroderma skin during the COVID-19 pandemic
Julia Spierings, Voon Ong, Christopher P Denton

Annals of the Rheumatic Diseases Jun 2021, 80 (6) 819-820; DOI: 10.1136/annrheumdis-2020-219775
Effects of face masks on oxygen saturation and functional measures in patients with connective tissue disorder-associated interstitial lung disease
Anuroopa Vijayan, Sakir Ahmed, Sneha Joseph, Aswathy Sukumaran, Subin Ahmed, Padmanabha Shenoy

Annals of the Rheumatic Diseases May 2021, annrheumdis-2021-220230; DOI: 10.1136/annrheumdis-2021-220230
New composite endpoint in early diffuse cutaneous systemic sclerosis: revisiting the provisional American College of Rheumatology Composite Response Index in Systemic Sclerosis
Dinesh Khanna, Suiyuan Huang, Celia J F Lin, Cathie Spino

Annals of the Rheumatic Diseases May 2021, 80 (5) 641-650; DOI: 10.1136/annrheumdis-2020-219100
Anti-centromere antibodies target centromere–kinetochore macrocomplex: a comprehensive autoantigen profiling
Nobuhiko Kajio, Masaru Takeshita, Katsuya Suzuki, Yukari Kaneda, Humitsugu Yamane, Kazuhiro Ikeura, Hidekazu Sato, Shin Kato, Hiroyuki Shimizu, Kazuyuki Tsunoda, Tsutomu Takeuchi

Annals of the Rheumatic Diseases May 2021, 80 (5) 651-659; DOI: 10.1136/annrheumdis-2020-218881
Response to: ‘Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic’ by Santos-Moreno et al
Emanuele Bozzalla Cassione, Giovanni Zanframundo, Alessandro Biglia, Veronica Codullo, Carlomaurizio Montecucco, Lorenzo Cavagna

Annals of the Rheumatic Diseases May 2021, 80 (5) e66; DOI: 10.1136/annrheumdis-2020-218193
Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab
Jérôme Avouac, Paolo Airó, Nicolas Carlier, Marco Matucci-Cerinic, Yannick Allanore

Annals of the Rheumatic Diseases Mar 2021, 80 (3) e37; DOI: 10.1136/annrheumdis-2020-217864

Main menu

scleroderma

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

scleroderma

Pages